Pfizer Stock Rises on Upbeat 2025 Outlook and Guidance
Pfizer’s (PFE) stock climbed in pre-market trading on Tuesday after the pharmaceutical giant shared a positive full-year outlook for 2025. The company’s projections align closely with Wall Street estimates, signaling stability and
